Victory Capital Management’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.01M Sell
95,137
-13,130
-12% -$954K 0.01% 1158
2025
Q4
$8.17M Sell
108,267
-108,946
-50% -$6.86M ﹤0.01% 1116
2025
Q3
$8.63M Sell
217,213
-37,557
-15% -$1.43M 0.01% 1158
2025
Q2
$11.1M Buy
254,770
+21,787
+9% +$829K 0.01% 1077
2025
Q1
$8.7M Buy
232,983
+9,921
+4% +$384K 0.01% 1107
2024
Q4
$10.1M Sell
223,062
-123,296
-36% -$6.29M 0.01% 1086
2024
Q3
$20.3M Buy
346,358
+190,092
+122% +$9.11M 0.02% 842
2024
Q2
$6.15M Buy
156,266
+56,607
+57% +$2.75M 0.01% 1205
2024
Q1
$6.62M Buy
99,659
+83,839
+530% +$3.66M 0.01% 1169
2023
Q4
$442K Hold
15,820
﹤0.01% 2028
2023
Q3
$337K Buy
+15,820
New +$349K ﹤0.01% 2088

Other funds holding APGE